Iminosugar‐Based Galactoside Mimics as Inhibitors of Galactocerebrosidase: SAR Studies and Comparison with Other Lysosomal Galactosidases

No abstract is available for this paper.

• Publication year

  2014

• Venue

  ChemMedChem

• Publication date

  2014-12-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/cmdc.201402411PMID 25377381
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacological chaperones increase residual β-galactocerebrosidase activity in fibroblasts from Krabbe patients.

  2014cited by this paper
• Stereoselective synthesis of 1-C-alkyl iminogalactitol derivatives, potential chaperones for galactosidase-linked LSDs: a real challenge

  2014cited by this paper
• Pharmacological chaperones as therapeutics for lysosomal storage diseases.

  2013cited by this paper
• An improved methodology for the synthesis of 1-C-allyl imino-d-xylitol and -l-arabinitol and their rapid functionalization

  2013cited by this paper
• A high-throughput screening assay using Krabbe disease patient cells.

  2013cited by this paper
• Glucosylceramide Mimics: Highly Potent GCase Inhibitors and Selective Pharmacological Chaperones for Mutations Associated with Types 1 and 2 Gaucher Disease

  2013cited by this paper
• A Phase 2 study of migalastat hydrochloride in females with Fabry disease: selection of population, safety and pharmacodynamic effects.

  2013cited by this paper
• Evaluation of N-nonyl-deoxygalactonojirimycin as a pharmacological chaperone for human GM1 gangliosidosis leads to identification of a feline model suitable for testing enzyme enhancement therapy.

  2012cited by this paper
• Pharmacological chaperone therapy for Fabry disease

  2012cited by this paper
• Aza-Claisen rearrangement of 2-C-hydroxymethyl glycals as a versatile strategy towards synthesis of isofagomine and related biologically important azasugars.

  2012cited by this paper
• Extended normal life after AAVrh10-mediated gene therapy in the mouse model of Krabbe disease.

  2012cited by this paper
• Synthesis of three branched iminosugars [(3R,4R,5S)-3-(hydroxymethyl)piperidine-3,4,5-triol, (3R,4R,5R)-3-(hydroxymethyl)piperidine-3,4,5-triol and (3S,4R,5R)-3-(hydroxymethyl)piperidine-3,4,5-triol] and a branched trihydroxynipecotic acid [(3R,4R,5R)-3,4,5-trihydroxypiperidine-3-carboxylic acid] fr

  2012cited by this paper
• Tuning glycosidase inhibition through aglycone interactions: pharmacological chaperones for Fabry disease and GM1 gangliosidosis.

  2012cited by this paper
• Docking and SAR studies of D- and L-isofagomine isomers as human β-glucocerebrosidase inhibitors.

  2011cited by this paper
• 1-C-Alkyl imino-d-xylitol and -l-arabinitol derivatives obtained via nucleophilic addition to pentose-derived N-tert-butanesulfinyl imines: sugar- versus chiral auxiliary-induced stereoselectivity

  2011cited by this paper
• Insights into Krabbe disease from structures of galactocerebrosidase

  2011cited by this paper
• Crystal Structure of Human β-Galactosidase

  2011cited by this paper
• 5-Trihydroxypropyl-dihydrouracil derivatives as precursors of 1-azasugars: application to the stereoselective synthesis of d-galacto-isofagomine

  2010cited by this paper
• DLHex-DGJ, a novel derivative of 1-deoxygalactonojirimycin with pharmacological chaperone activity in human G(M1)-gangliosidosis fibroblasts.

  2010cited by this paper
• Molecular Characterization of Mutations That Cause Globoid Cell Leukodystrophy and Pharmacological Rescue Using Small Molecule Chemical Chaperones

  2010cited by this paper
• The long-term outcomes of presymptomatic infants transplanted for Krabbe disease: Report of the workshop held on July 11 and 12, 2008, Holiday Valley, New York

  2009cited by this paper
• Iminosugars as Active‐Site‐Specific Chaperones for the Treatment of Lysosomal Storage Disorders

  2008cited by this paper
• Asymmetric synthesis of all stereoisomers of isofagomine using [2,3]-wittig rearrangement

  2007cited by this paper
• Single‐dose intracerebroventricular administration of galactocerebrosidase improves survival in a mouse model of globoid cell leukodystrophy

  2007cited by this paper
• Design and Synthesis of Highly Potent and Selective Pharmacological Chaperones for the Treatment of Gaucher's disease

  2006cited by this paper
• Synthesis of a Fusion‐Isomeric Cellobionoimidazole and Its Evaluation against the syn‐Protonating Glycosidase Cel7A

  2005cited by this paper
• Screening for lysosomal disorders

  2005cited by this paper
• A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity.

  2003cited by this paper
• Chemical chaperone therapy for brain pathology in GM1-gangliosidosis

  2003cited by this paper
• Krabbe disease: genetic aspects and progress toward therapy.

  2000cited by this paper
• A Large Difference in the Thermodynamics of Binding of Isofagomine and 1-Deoxynojirimycin to β-Glucosidase

  2000cited by this paper
• Chemoenzymatic synthesis of isogalactofagomine.

  2000cited by this paper
• Recent Insights into Inhibition, Structure, and Mechanism of Configuration-Retaining Glycosidases.

  1999cited by this paper
• Neue Erkenntnisse über Hemmung, Struktur und Mechanismus konfigurationserhaltender Glycosidasen

  1999cited by this paper
• 1-N-Iminosugars: Potent and Selective Inhibitors of β-Glycosidases

  1998cited by this paper
• Twenty Five Years of the “Psychosine Hypothesis”: A Personal Perspective of its History and Present Status

  1998cited by this paper
• The Molecular and Genetic Basis of Neurological Disease

  1995cited by this paper
• Facile synthesis of a new type of iminosugar: a nitrogen atom is in the anomeric position.

  1995cited by this paper
• A new family of five-carbon iminoalditols which are potent glycosidase inhibitors

  1990cited by this paper
• Pseudomonic acid C from L-lyxose

  1985cited by this paper
• Progressive accumulation of toxic metabolite in a genetic leukodystrophy.

  1984cited by this paper
• An improved method for the identification of patients and carriers of Krabbe's disease.

  1974cited by this paper
• Globoid cell leucodystrophy (Krabbe's disease): deficiency of galactocerebroside beta-galactosidase.

  1970cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Decoding the function of the human glycome using chemical glycoprobes and glycosensor arrays.

  2025cites this paper
• Stereoselective ring contractions in glycopyranosides as key-step en route to isoiminosugars.

  2025cites this paper
• Synthesis of C-glycoside analogues of isopropyl β-D-1-thiogalactopyranoside (IPTG) and 1-β-D-galactopyranosyl-2-methylpropane. Conformational analysis and evaluation as inhibitors of the lac repressor in E. coli and as galactosidase inhibitors.

  2024cites this paper
• A concise synthetic approach for isoiminosugars.

  2024cites this paper
• From pathological mechanisms in Krabbe disease to cutting‐edge therapy: A comprehensive review

  2024cites this paper
• Solvent-controlled synthesis of bulky and polar-bulky galactonoamidines.

  2022cites this paper
• Rational design of cell active C2-modified DGJ analogues for the inhibition of human α-galactosidase A (GALA).

  2021cites this paper
• Asymmetric hydrogenation of exocyclic γ,δ-unsaturated β-ketoesters to functionalized chiral allylic alcohols via dynamic kinetic resolution

  2021cites this paper
• Synthesis of multimeric pyrrolidine iminosugar inhibitors of human β-glucocerebrosidase and α-galactosidase A: First example of a multivalent enzyme activity enhancer for Fabry disease.

  2020cites this paper
• Synthesis of Isofagomine Derivatives as New Fluorescence pH Indicators/Glycosidase Inhibitors

  2020cites this paper
• Synthesis of “All-Cis” Trihydroxypiperidines from a Carbohydrate-Derived Ketone: Hints for the Design of New β-Gal and GCase Inhibitors

  2020cites this paper
• Iminosugars

  2020cites this paper
• 4-epi-Isofagomine derivatives as pharmacological chaperones for the treatment of lysosomal diseases linked to β-galactosidase mutations: Improved synthesis and biological investigations.

  2018cites this paper
• Strategies Toward Protection of 1,2‐ and 1,3‐Diols in Carbohydrate Chemistry

  2018cites this paper
• A Specific Activity‐Based Probe to Monitor Family GH59 Galactosylceramidase, the Enzyme Deficient in Krabbe Disease

  2017cites this paper
• Application of fluorescent β-glucopyrano-syl-configured cyclophellitol-aziridines for simultaneous differential fluorescent labeling of β-glucosidases and β-galactosidases

  2017cites this paper
• Conformationally-locked C-glycosides: tuning aglycone interactions for optimal chaperone behaviour in Gaucher fibroblasts.

  2016cites this paper
• Synthesis of C-5a-substituted derivatives of 4-epi-isofagomine: notable β-galactosidase inhibitors and activity promotors of GM1-gangliosidosis related human lysosomal β-galactosidase mutant R201C.

  2016cites this paper
• Synthesis and evaluation of N-alkylated analogues of aza-galacto-fagomine - potential pharmacological chaperones for Krabbe disease.

  2016cites this paper
• New therapeutic approaches for Krabbe disease: The potential of pharmacological chaperones

  2016influential citation
• Chaperones as potential therapeutics for Krabbe disease

  2016cites this paper
• N‐Alkyl‐, 1‐C‐Alkyl‐, and 5‐C‐Alkyl‐1,5‐dideoxy‐1,5‐imino‐(l)‐ribitols as Galactosidase Inhibitors

  2016cites this paper
• Carbohydrate-Processing Enzymes of the Lysosome: Diseases Caused by Misfolded Mutants and Sugar Mimetics as Correcting Pharmacological Chaperones.

  2016cites this paper
• pH-Responsive Pharmacological Chaperones for Rescuing Mutant Glycosidases.

  2015cites this paper
• Azasugar inhibitors as pharmacological chaperones for Krabbe disease

  2015cites this paper